The board of directors of AbbVie Inc (NYSE:ABBV) declared on Thursday its quarterly dividend of USD1.07 per share of its stock.

This cash dividend is due on 15 May 2019 to stockholders of record at the close of business as of 15 April 2019.

Since the company's inception in 2013, it has increased its dividend by 168%.

According to the research and development-based biopharmaceutical company, it is committed to developing innovative advanced therapies for some of the world's most complex and critical conditions.